MPO and colitis: Glabridin ameliorates dextran sulfate sodium-induced colitis in mice by reducing colonic myeloperoxidase activity and the production of inflammatory mediators, such as nitric oxide, prostaglandin E2, and proinflammatory cytokines (Kwon et al., 2008).